Tumor-infiltrating neutrophils (TIN) carry out quite significant but opposite functions in different cancers, and their function in biliary cancer has not been fully characterized. To investigate the prognostic significance of TIN in biliary cancer, a training set (n = 118) and a validation set (n = 127) were involved in this study. TIN were evaluated by immunohistochemical staining of CD66b, and then defined as low (neutrophils <18/high-power field [HPF]) vs high (neutrophils ≥18/HPF). Kaplan-Meier curve, Cox proportional hazards models and receiver operating characteristic curve were used to assess the prognostic significance. TIN was identified as an independent prognostic factor for overall survival in the training set (HR: 4.720; 95% CI: 2.623-8.493; P < .001) which was confirmed in the validation set (HR: 4.993; 95% CI: 2.626-9.492; P < .001). Notably, among patients with stage III and IV disease, those with low TIN could benefit from adjuvant chemotherapy, with a reduced risk of compromised survival compared with those with high TIN (HR: 0.294; 95% CI: 0.099-0.873; P = .047 in the training set; and HR: 0.100; 95% CI: 0.022-0.462; P = .006 in the validation set). In addition, TIN were negatively related to biological pathways as regulation of activated T-cell proliferation and lymphocyte-mediated immunity, and showed a negative correlation with CD8 + T cells (r = À.324, P < .001). Taken together, our results implicate TIN as an independent marker of prognosis and indicator of patients who would benefit from adjuvant chemotherapy in biliary cancer.
cancer, but prognosis of patients receiving radical operation is still unsatisfactory with a 5-year survival rate of 24% to 53%. 4 Local recurrence is regarded as a main limitation for postoperative patients with biliary cancer, making ACT extremely critical. Nevertheless, a substantial body of literature provided conflicting evidence regarding the role of ACT for biliary cancer. 5, 6 Precise risk stratification for biliary cancer patients that can be used to predict ACT response is urgently needed.
As 1 of the 10 hallmarks of cancer, inflammation is described as a "wound that does not heal", and is the most prevalent risk factor for biliary cancer, which mainly manifests as cholelithiasis and calcification for gallbladder cancer, and primary sclerosing cholangitis and choledochal cysts for cholangiocarcinoma. 7, 8 As indispensable antagonists of microbial infection and facilitators of wound healing, neutrophils play an important role in inflammation. In recent years, the profound influence of TIN throughout each step of carcinogenesis has been seen: from tumor initiation to primary tumor growth to metastasis. 9 It was reported that TIN have a protumor role through induction of angiogenesis, 10, 11 immunosuppression, 12 counteracting senescence, 13 stimulating cancer cell migration, and guiding cancer cells into tissue. 14, 15 However, some other intriguing literature has reported the antitumor function of TIN through their cytotoxic effects mediated by H 2 O 2 16 or antibody-dependent cellular cytotoxicity. 17 These completely opposite roles of TIN promoted the distinction of antitumor (N1) and protumor (N2) neutrophils. 9, 18 Similarly, the prognostic effect of TIN is also multifarious. Positive correlations with patient survival were observed in gastric cancer, 19 whereas negative correlations were observed in hepatoma, 20 melanoma, 21 renal cancer 22 and lung cancer. 23 As in biliary cancer, the role of TIN has not been investigated extensively.
With regard to the critical value of TIN in the TME, in the present study, we evaluated the level of TIN in biliary cancer, assessed its relationship with clinical outcome, especially with ACT, and explored the effect of TIN on other TME components. These results might illustrate the importance of TIN, develop a promising prognostic system to predict the outcome of patients receiving ACT, and help improve the understanding of TME in biliary cancer.
| PATIENTS AND METHODS

| Study design
Two independent sets comprising 245 consecutive patients with biliary cancer undergoing surgical resection with the aim of cure were enrolled into the present study from Shanghai Zhongshan Hospital in | 2267 distinction will tend to show the latter distribution. Herein, a total of 36 random sample permutations of cholangiocarcinoma in The Cancer Genome Atlas (TCGA) database were divided into a low TIN group and a high TIN group by CIBERSORT, and then GSEA was carried out to determine the pathways that showed statistically significant and concordant differences between a low-TIN state and a high-TIN state by MSigDB. If the majority of genes included in a gene set are primarily found at the top or the bottom, there will be a positive enrichment score (ES) and a normalized enrichment score (NES), indicating the different expression patterns between the predefined low-TIN group and the high-TIN group. 
| Statistical analyses
| RESULTS
| Immunohistochemical findings
Tumor-infiltrating neutrophils were evaluated by immunohistochemical staining of CD66b. Neutrophils infiltrating tumor tissues varied greatly in different specimens of biliary cancer ( Figure 1A ) and ranged from 0 to 226 cells/HPF. The median value (18/HPF) was set as the cutoff value which determined high and low TIN in the training set, and was then applied to the validation set. To estimate the heterogeneity of TME, we explored the distribution of CD66-positive cells using 20 cases of normal sections. As shown in Figure S1 , ICC is 0.849, which means that the intensity of CD66-positive cells in a randomized field could be an ideal representation of that in the normal section. In other words, the intensity of CD66-positive cells in TMA could also be an ideal representation of that in the normal section.
| Patient characteristics
Baseline characteristics of patients are described in Tables 1, S1 , and (Table S2 ).
| Correlations between TIN and OS
To identify the prognostic value of TIN, we compared the OS between different groups according to TIN level by Kaplan-Meier survival analysis. Sixty and 56 patients died before the last follow up in the training set and validation set, respectively. As shown in Fig- ure 1B,C and D, patients with high-TIN disease showed compromised OS compared to those with low-TIN disease in the training (P < .001), validation (P < .001) and combined sets (P < .001).
| Univariate and multivariate regression analyses
Univariate analysis was carried out for OS to further identify the clinical significance of TIN. As shown in CI: 3.050-7.206; P < .001 in the combined set; Table 2 , respectively).
In addition, TNM stage was also identified to be significantly associated with OS in all 3 sets (P < .001). Moreover, tumor location (P = .028) was identified to be significantly associated with OS in the training set, as was differentiation in the validation set (P = .029) and surgical margin and microvascular invasion in the combined set (P = .038 and P = .011, respectively). These factors were then entered into the multivariate Cox proportional hazards model, and we found that only TIN (HR: 4.213; 95% CI: 2.320-7.650; P < .001; HR: 4.010; 95% CI: 2.217-7.253; P < .001; and HR: 4.133; 95% CI:
2.660-6.423; P < .001; Table 2 , respectively) and TNM stage (P < .001) were independent prognostic indicators for OS.
| Extension of prognostic models with TIN
In view of the distinctly prognostic value, we integrated TIN into the TNM staging system to explore the practical application of TIN. ROC analysis was carried out to assess the prognostic accuracy. As shown in Figure 1E , the area under the curve (AUC) of TNM stage alone was 0.755 (95% CI: 0.694-0.816), and was elevated to 0.834 (95% CI: 0.784-0.884) when TIN were added.
| Correlations between TIN and ACT
According to patient characteristics, we evaluated the association between ACT and OS. In patients with stage III and IV disease, those with high TIN could not benefit from ACT in training, validation and combined sets (P = .415, P = .735, P = .556, Figure 2A ,C,E, respectively). However, those patients with low TIN could benefit greatly from ACT (P = .047, P = .006, P = .002, Figure 2B ,D,F, respectively). 95% CI: 0.090-0.520; P = .002 in the combined set; Table 3 , respectively), whereas such risk reduction was not observed in patients with high TIN (Table 3 ) and in patients with stage II disease (Figure S2 ).
| Interaction between TIN and other TME components
Given the interaction above and the ability of TIN to influence CD8 + T cells suggested previously, 30 (Table S3) . Moreover, infiltration of CD8 + T cells was related to favorable OS ( Figure 3H ), and the combination of TIN and CD8 + T cells indicated that patients with high-TIN and low-CD8 + T-cell disease experienced the shortest OS compared with any other subgroup ( Figure 3I ). These results indicated that high TIN was 
| DISCUSSION
As the most common prognostic model for patients with biliary cancer, the TNM staging system focuses only on cancer-cell-centered biological phenotypes and ignores the enormous effects of TME, which lead to obvious reduction of prognostic accuracy. That is the reason why so many early-stage patients progress rapidly, whereas some advanced-stage patients maintain a relatively stable state for years. In the present study, we proved the prognostic significance of TIN, identified it as an independent prognostic marker for OS in patients with biliary cancer and integrated it into the TNM staging system to elevate its prognostic value. Furthermore, TIN might be a potential predictive marker for the response of ACT in biliary cancer.
It was reported that neutrophils can survive longer in tumor tissue than in spleen even for several days, 31, 32 which means TIN might have more far-reaching effects on TME than we have previously realized. As reported previously, neutrophils can suppress CD8 + T cellmediated antitumor immune response by inducible nitric oxide synthase (iNOS) and arginase 1 (ARG1). 30 In the present study, we found that TIN in biliary cancer were negatively correlated with CD8 + T cells which is an important preserver of antitumor response 48 and has already proven to be a favorable marker as mentioned earlier. Also, we verified that high TIN was related to inhibition of antitumor immune effector through GSEA. These results Results of continuous variables are presented as mean AE SD. Combined set was generated by combing the training and validation set together.
indicate that high TIN was correlated with immunosuppression in TME of biliary cancer and may be the reason for poor prognosis and ACT efficacy.
Limitations of our study are the retrospective nature, relatively small number of patients, as well as the unavailability of full chemotherapy details for the entire cohorts. In addition, although CD66b have a high purity to identify TIN in TME, it is not an extremely specific marker for neutrophils. Therefore, these results need to be validated by a future prospective, multicenter randomized trial with a larger population.
In conclusion, TIN could be used as an independent prognostic factor for prognosis and ACT benefit in biliary cancer patients, especially for patients with stage III and IV disease.
T A B L E 3 Hazard ratios for overall survival in stage III and IV biliary cancer patients receiving ACT or not according to TIN F I G U R E 3 Association between tumor-infiltrating neutrophils (TIN) and CD8 + T cells. A-D, Continuous sections from biliary cancer samples immunohistochemically stained for CD66b and CD8. Scale bars, 100 lm; magnification 2009. E, Spearman's correlation analysis for TIN counts and CD8 + T-cell counts. F, Gene Set Enrichment Analysis (GSEA) of regulation of activated T-cell proliferation between the low-TIN group and the high-TIN group. ES, enriched score; NES, normalized enriched score; NOM, P-value, normalized P-value. G, GSEA of regulation of lymphocyte-mediated immunity between the low-TIN group and the high-TIN group. H, CD8 + T-cell infiltration in biliary cancer is associated with favorable prognosis. Kaplan-Meier curves illustrating overall survival (OS) probability according to CD8 + T-cell density. I, Combination of TIN and CD8 + T cells indicated that patients with high TIN and low CD8 + T cells experienced the shortest OS
